FSD Pharma Inc. submitted a Form 6-K report to the SEC on June 12, 2024, regarding its compliance with securities regulations. This filing is primarily for administrative purposes, confirming the company's details and filing status.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.